Qualification: Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.

Record: kaal:position:2026-07-31-1510 · 2026-07-31

Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization. should be assessed against Kaal's source-bound claim that The SEC, rather than the courts or Congress, is the institution positioned to implement a choice of law regime for securities transactions, through rulemaking. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.
Holds when
Current debate

Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.

Scholarly basis

kaal:claim:2029983-035
Wulf A. Kaal, Richard W. Painter, Forum Competition and Choice of Law Competition in Securities Law after Morrison v. National Austral (2012). SSRN: https://ssrn.com/abstract=2029983
Source PDF sha256: fde2ff611420eb283cbb49a6b681a2ae8efa2b4603ae71480e2d91483f0295f2

Evidence and mapping

Evidence: metadata only
Review tier: mapping review before claim review
Mapping confidence: 0.2972
Mapping ambiguous: true

Topics

dynamic-regulationsecurities-lawlaw-and-legal-systems

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0007 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: ceec39259ec96ab13fc70601577ec4ea61f252aa3a26d746405d2fb2b697e27b
curl -s https://wulfkaal.github.io/positions/2026-07-31-1510.md | sha256sum